Bristol-Myers Squibb
Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMY
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.
BMY Key Statistics
Stock Snapshot
With a market cap of 122.77B, Bristol-Myers Squibb(BMY) trades at $60.35. The stock has a price-to-earnings ratio of 17.27 and currently yields dividends of 4.2%.
As of 2026-02-20, Bristol-Myers Squibb(BMY) stock has fluctuated between $59.24 and $60.40. The current price stands at $60.35, placing the stock +1.9% above today's low and -0.1% off the high.
The Bristol-Myers Squibb(BMY)'s current trading volume is 13.33M, compared to an average daily volume of 13.95M.
In the last year, Bristol-Myers Squibb(BMY) shares hit a 52-week high of $63.33 and a 52-week low of $42.52.
In the last year, Bristol-Myers Squibb(BMY) shares hit a 52-week high of $63.33 and a 52-week low of $42.52.
BMY News
Bristol-Myers Squibb Company ( ) announced a healthy earnings result recently, and the market rewarded it with a strong uplift in the stock price. This reaction...
William Blair analyst Matt Phipps has maintained their neutral stance on BMY stock, giving a Hold rating today. Matt Phipps has given his Hold rating due to a...
In early February 2026, Bristol-Myers Squibb reported fourth-quarter 2025 revenue of US$12,502 million and net income of US$1,087 million, while confirming comp...
Analyst ratings
57%
of 30 ratingsMore BMY News
Bristol-Myers Squibb (BMY) is back in focus after reporting fourth quarter and full year 2025 results that beat consensus expectations, with newer drugs and cos...
Bristol-Myers Squibb Company (BMY) announced an update on their ongoing clinical study. The LIBREXIA-STROKE study tests milvexian in people who recently had an...
Bristol-Myers Squibb Company (BMY) announced an update on their ongoing clinical study. The Asia Myelodysplastic Syndrome (MDS) Registry is an observational st...
Bristol-Myers Squibb (NYSE:BMY) reported strong fourth quarter earnings, supported by a growth portfolio that includes several products now generating more than...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.